Jun. 04, 2014
Posted at June 4, 2014 1:47 pm by Peter L Saltonstall

One Response to Thoughtful Biosimilars Policy Is Best Way to Ensure Optimum Patient Outcomes

  1. Hero Life says:

    Thank you for putting forth the letter to the Commissioner on the behalf of the rare disease community highlighting the importance for guiding policy for approval of potential biosimilar therapies.

Leave a Reply

*

EURORDISRare Disease Day USNORD